Preparing for Antimicrobial Resistance: Vision and Social Science Mission of the INAMRSS Network
While drug-resistant infections pose a well-known and severe threat to human and animal health, the COVID-19 pandemic is compounding this situation.
Antibiotics
-
Read more: Preparing for Antimicrobial Resistance: Vision and Social Science Mission of the INAMRSS Network -
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from October 2020.
-
Read more: Resistance (the Film) – Thursday Night in Brookline Resistance (the Film) – Thursday Night in Brookline
At the Coolidge Corner Theater in Brookline, MA this Thursday – more info here: @koutterson
-
Read more: Ebola in the New Yorker (but no Ebola in New York, thankfully) Ebola in the New Yorker (but no Ebola in New York, thankfully)
By Kevin Outterson A short article in the New Yorker on my favorite topic – business models for antibiotic use and innovation.
-
Read more: The Revival of Phage Therapy to Fight Antimicrobial Resistance (AMR) – Part III: What about patent protection and alternative incentives? The Revival of Phage Therapy to Fight Antimicrobial Resistance (AMR) – Part III: What about patent protection and alternative incentives?
By Timo Minssen In Part II of this blog on legal issues relating to the revival of phage therapy I discussed the US Supreme Court’s decisions in Myriad and Prometheus, which might present major obstacles to the patentability of phage-related technology (a more detailed analysis of the Myriad and Prometheus decisions is available here). Yet,…
-
Read more: The Revival of Phage Therapy to Fight Antimicrobial Resistance – Part I: What are the legal implications? The Revival of Phage Therapy to Fight Antimicrobial Resistance – Part I: What are the legal implications?
By Timo Minssen Last week I blogged about recent publications concerning the global battle against anti-microbial resistance (AMR). I did not mention a recent paper published in the June 2014 issue of Nature, which describes how European and U.S. researchers and authorities are increasingly considering clinical research in unconventional areas to fight AMR. The news-report…
-
Read more: The Fight Against Antimicrobial Resistance: Important recent publications The Fight Against Antimicrobial Resistance: Important recent publications
By Timo Minssen One of my previous blogs discussed the growing threat of antimicrobial resistance (AMR). I concluded that antimicrobial resistance is a growing and complex threat involving multifaceted legal, socio-economic and scientific aspects. This requires sustained and coordinated action on both global and local levels. A recent medical review on drug resistant tuberculosis supports…